Drug Shortage Report for QUETIAPINE XR
Report ID | 8290 |
Drug Identification Number | 02417383 |
Brand name | QUETIAPINE XR |
Common or Proper name | QUETIAPINE XR |
Company Name | SIVEM PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | QUETIAPINE |
Strength(s) | 300MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL |
Packaging size | 60 |
ATC code | N05AH |
ATC description | ANTIPSYCHOTICS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2017-05-17 |
Actual start date | |
Estimated end date | 2017-06-15 |
Actual end date | 2017-05-01 |
Shortage status | Avoided shortage |
Updated date | 2017-05-18 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 4705 DOBRIN STREET SAINT-LAURENT, QUEBEC CANADA H4R 2P7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2017-05-18 | French | Compare |
v4 | 2017-05-18 | English | Compare |
v3 | 2017-05-18 | English | Compare |
v2 | 2017-04-27 | French | Compare |
v1 | 2017-04-27 | English | Compare |
Showing 1 to 5 of 5